ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Normative data for subcortical regional volumes over the lifetime of the adult human brain

Potvin, Olivier; Mouiha, Abderazzak; Dieumegarde, Louis; Duchesne, Simon*
NeuroImage2016-8-15DOI: 10.1016/j.neuroimage.2016.05.016
96被引5阅读
引用收藏
分享

摘要

Normative data for volumetric estimates of brain structures are necessary to adequately assess brain volume alterations in individuals with suspected neurological or psychiatric conditions. Although many studies have described age and sex effects in healthy individuals for brain morphometry assessed via magnetic resonance imaging, proper normative values allowing to quantify potential brain abnormalities are needed. We developed norms for volumetric estimates of subcortical brain regions based on cross-sectional magnetic resonance scans from 2790 healthy individuals aged 18 to 94 years using 23 samples provided by 21 independent research groups. The segmentation was conducted using FreeSurfer, a widely used and freely available automated segmentation software. Models predicting subcortical regional volumes of each hemisphere were produced including age, sex, estimated total intracranial volume (eTIV), scanner manufacturer, magnetic field strength, and interactions as predictors. The mean explained variance by the models was 48%. For most regions, age, sex and eTIV predicted most of the explained variance while manufacturer, magnetic field strength and interactions predicted a limited amount. Estimates of the expected volumes of an individual based on its characteristics and the scanner characteristics can be obtained using derived formulas. For a new individual, significance test for volume abnormality, effect size and estimated percentage of the normative population with a smaller volume can be obtained. Normative values were validated in independent samples of healthy adults and in adults with Alzheimer's disease and schizophrenia.

学科与关键词

关键词
Magnetic resonance imagingAtrophyMorphometryNormalityAgingSex
相关
加载中…
  • QUANTITATIVE VOLUMETRIC-ANALYSIS OF BRAIN MR - NORMATIVE DATABASE SPANNING 5 DECADES OF LIFE
    BLATTER, DD*; BIGLER, ED; GALE, SD; JOHNSON, SC; ANDERSON, CV; BURNETT, BM; PARKER, N; KURTH, S; HORN, SDAJNR. American journal of neuroradiology, 1995, 16(2): 241-251.被引 391
  • Variance in Brain Volume with Advancing Age: Implications for Defining the Limits of Normality
    Dickie, David Alexander; Job, Dominic E.*; Gonzalez, David Rodriguez; Shenkin, Susan D.; Ahearn, Trevor S.; Murray, Alison D.; Wardlaw, Joanna M.PLoS One, 2013, 8(12): e84093.被引 29
  • A voxel-based morphometric study of ageing in 465 normal adult human brains
    Good, CD*; Johnsrude, IS; Ashburner, J; Henson, RNA; Friston, KJ; Frackowiak, RSJNeuroImage, 2001, 14(1): 21-36.被引 3759
查看全部 →

发表信息

论文状态
公开发表
期刊
NeuroImage
发表日期
2016-08-15
卷期
第 137 卷
页码
9-20
DOI
10.1016/j.neuroimage.2016.05.016
语言
ENGLISH
成果收录
SCIE
资助标注
Alzheimer's Society of Canada [13-32]; Canadian Foundation for Innovation [30469]; Fonds de recherche du Quebec - Sante/Pfizer Canada Pfizer-FRQS Innovation Fund [25262]; Canadian Institutes for Health Research [117121]; NIMH [K23MH087770, R01MH081218, R01MH083246, R21MH084126]; Leon Levy Foundation; ADNI (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Commonwealth Scientific and Industrial Research Organisation (CSIRO); National Multiple Sclerosis Society; National Institute of Health [COBRE: 1P20RR021938-01A2]; NSF Grant [OCI-1131441]; Biomedical Informatics Research Network [U24-RR021992]; Dana Foundation; John Douglas French Alzheimer's Foundation; National Institutes of Health [AT005733, HD059205, HD057610, NS073498, NS058899]; UK Alzheimer's Society [RF116]; GlaxoSmithKline [6GKC]; NIMH BRAINS [R01MH094639-01]; New York State Office of Mental Health and Research Foundation for Mental Hygiene; Child Mind Institute [1FDN2012-1]; Center for the Developing Brain at the Child Mind Institute; NKI Center for Advanced Brain Imaging (CABI); Brain Research Foundation; Stavros Niarchos Foundation; NIH [

作者

  • P

    Potvin, Olivier (第一作者)

  • M

    Mouiha, Abderazzak

查看全部 4 位作者收起作者
  • D

    Dieumegarde, Louis

  • D

    Duchesne, Simon (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417